Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAPATI: Vincristine PK and Toxicity in African Children
NCT05844670Phase 4Unknown
- Sponsor
- Moi University
- Start
- Apr 2023
- Primary completion
- Aug 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vincristine in acute lymphoblastic leukemia (ALL), non-Hodgkin lymphoma (NHL), rhabdomyosarcoma (RMS), neuroblastoma, Wilms tumor (WT), sponsored by Moi University. Status: unknown.
02
Drugs
vincristine
03
Conditions
acute lymphoblastic leukemia (ALL)non-Hodgkin lymphoma (NHL)rhabdomyosarcoma (RMS)neuroblastomaWilms tumor (WT)
Beyond the preview
Go deeper on NCT05844670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05844670.